Stoke Therapeutics Inc (STOK)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2019 | 09-2019 | 06-2019 | 03-2019 | 12-2018 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 222,471 | 233,049 | 242,680 | 0 | N/A |
| Receivables | 281 | 376 | 260 | 0 | N/A |
| TOTAL | $226,033 | $236,680 | $244,445 | $0 | $N/A |
| Non-Current Assets | |||||
| PPE Net | 2,512 | 1,942 | 1,722 | N/A | N/A |
| Other Non-Current Assets | 205 | 205 | 205 | 0 | 0 |
| TOTAL | $2,717 | $2,147 | $1,927 | $N/A | $N/A |
| Total Assets | $228,750 | $238,827 | $246,372 | $0 | $N/A |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 751 | 1,789 | 1,238 | 0 | 0 |
| Accrued Expenses | 3,350 | 3,127 | 3,580 | 0 | N/A |
| TOTAL | $4,101 | $4,916 | $4,818 | $0 | $N/A |
| Non-Current Liabilities | |||||
| Other Non-Current Liabilities | 221 | 228 | 18 | 0 | 0 |
| TOTAL | $221 | $228 | $18 | $N/A | $N/A |
| Total Liabilities | $4,322 | $5,144 | $4,836 | $0 | $N/A |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 32,944 | 32,730 | 32,718 | N/A | N/A |
| Common Shares | 3 | 3 | 3 | 0 | N/A |
| Retained earnings | -58,035 | -47,875 | -39,271 | 0 | N/A |
| TOTAL | $224,428 | $233,683 | $241,536 | $0 | $N/A |
| Total Liabilities And Equity | $228,750 | $238,827 | $246,372 | $0 | $0 |